Bendong, Avelino L.
HRN: 24-43-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/24/2025
10/31/2025
IV
500mg
Q8
Cholecystitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes